Become a Prof G+ subscriber for unlimited, ad-free access to all our videos, including ex
Continue any prescribed IBS medications unless advised otherwise, and maintain contact with your gastroenterologist if you have one
Hims & Hers will continue exploring opportunities to collaborate with partners, executives said
Exact numbers are hard to come by, but one company, Omada Health, told investors last month that its membership grew by 51% over the last year to more than a million people
In contrast, those using Tirzepatide achieved higher monthly weight loss percentages: approximately 5.9% after 3 months, 10.1% after 6 months, and 15.3% after 12 months, surpassing the weight loss observed with semaglutide